ENTITY

Isu Abxis (086890 KS)

3
Analysis
Health CareSouth Korea
ISU ABXIS Co., Ltd. develops therapeutic antibodies for such as antithrombus, anti-inflammatory, anti-cancer, and rare diseases. The Company also provides medical service such as anti-cancer drug sensitivity examination and gene examination.
more
08 Jan 2026 10:50

KRX Short Interest Weekly (Jan 2nd): NAVER, Alteogen, Samsung SDI, PEPTRON, LG Energy Solution

We analyzed KRX short interest report for the past week and highlighted short interest changes in NAVER, Alteogen, Samsung SDI, PEPTRON, LG Energy...

Logo
300 Views
Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
03 Dec 2025 07:00

KRX Short Interest Weekly (Nov 28th): Hanwha Ocean, SK Hynix, Kakaopay, NAVER

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanwha Ocean, SK Hynix, kakaopay, NAVER, HD...

Logo
297 Views
Share
No more insights
x